Second degree AV block primary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Primary prevention== | ==Primary prevention== | ||
* Effective measures for [[primary prevention ]] of [[atrioventricular block]] include treatment of [[hypertension]] and maintenance of normal [[blood glucose]] levels. | * Effective measures for [[primary prevention ]] of [[atrioventricular block]] include treatment of [[hypertension]] and maintenance of normal [[blood glucose]] levels.<ref name="pmid31125096">{{cite journal |vauthors=Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM |title=Risk Factors Associated With Atrioventricular Block |journal=JAMA Netw Open |volume=2 |issue=5 |pages=e194176 |date=May 2019 |pmid=31125096 |pmc=6632153 |doi=10.1001/jamanetworkopen.2019.4176 |url=}}</ref><ref name="pmid15364185">{{cite journal |vauthors=Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L |title=Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study |journal=Lancet |volume=364 |issue=9438 |pages=937–52 |date=2004 |pmid=15364185 |doi=10.1016/S0140-6736(04)17018-9 |url=}}</ref><ref name="pmid14237429">{{cite journal |vauthors=LEV M |title=ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK |journal=Am. J. Med. |volume=37 |issue= |pages=742–8 |date=November 1964 |pmid=14237429 |doi=10.1016/0002-9343(64)90022-1 |url=}}</ref>. | ||
* [[Atrioventricular]] (AV) block is a common reason for [[pacemaker]] implantation, and the number of [[pacemaker]] implantations is increasing. | * [[Atrioventricular]] (AV) block is a common reason for [[pacemaker]] implantation, and the number of [[pacemaker]] implantations is increasing. | ||
* [[Atrioventricular block]] most commonly occurs in the absence of significant [[cardiac]] disease and is generally attributed to idiopathic [[fibrosis]] of the conduction system. | * [[Atrioventricular block]] most commonly occurs in the absence of significant [[cardiac]] disease and is generally attributed to idiopathic [[fibrosis]] of the conduction system. | ||
* By definition, the cause of that [[fibrosis]] remains unknown without [[primary prevention]] strategy. | * By definition, the cause of that [[fibrosis]] remains unknown without [[primary prevention]] strategy. | ||
==References== | ==References== | ||
Revision as of 05:40, 11 July 2021
|
Second degree AV block Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Second degree AV block primary prevention On the Web |
|
American Roentgen Ray Society Images of Second degree AV block primary prevention |
|
Risk calculators and risk factors for Second degree AV block primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels. Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing. Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system. By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
Primary prevention
- Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels.[1][2][3].
- Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing.
- Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.
- By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM (May 2019). "Risk Factors Associated With Atrioventricular Block". JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study". Lancet. 364 (9438): 937–52. doi:10.1016/S0140-6736(04)17018-9. PMID 15364185.
- ↑ LEV M (November 1964). "ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK". Am. J. Med. 37: 742–8. doi:10.1016/0002-9343(64)90022-1. PMID 14237429.